UBS Loses Conviction In Spark Therapeutics, Downgrades

By: via Benzinga
Spark Therapeutics Inc (NASDAQ: ONCE) releasedphase 1/2 SPK-8011 data in hemophilia A treatment over the weekend that fell short ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.